MIEN1 and prostate carcinoma: Moreover, miR-940 was shown to suppress progression of prostate cancer and pancreatic ductal adenocarcinoma by suppressing Migration and invasion enhancer 1 (MIEN1) [9] and MyD88 [10], respectively.